Get started
Author

Chiara Molteni

Molecular Epidemiology Study of Exogenous Reinfection in an Area with a Low Incidence of Tuberculosis
2001 · Alessandra Bandera, Andrea Gori, et al. · Journal of Clinical Microbiology · 147
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
2020 · Francesco Perrone, Maria Carmela Piccirillo, et al. · Journal of Translational Medicine · 144
PDF
Weight Gain: A Possible Side Effect of All Antiretrovirals
2017 · Lucia Taramasso, Elena Ricci, et al. · Open Forum Infectious Diseases · 92
PDF
IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study
2021 · Marco Franzetti, Andrea Forastieri, et al. · The Journal of Immunology · 68
PDF
Low‐Dose Prolonged Intermittent Interleukin‐2 Adjuvant Therapy: Results of a Randomized Trial among Human Immunodeficiency Virus–Positive Patients with Advanced Immune Impairment
2002 · Giulia Marchetti, Luca Meroni, et al. · The Journal of Infectious Diseases · 61
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report
2020 · Marco Franzetti, Ugo Pozzetti, et al. · International Journal of Infectious Diseases · 45
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study
2019 · Paolo Maggi, Carmen R. Santoro, et al. · BMC Infectious Diseases · 41
PDF
Mycobacterium lentiflavumInfection in Immunocompetent Patient
2005 · Chiara Molteni, Lidia Gazzola, et al. · Emerging infectious diseases · 36
PDF
Factors associated with hospital admission for COVID-19 in HIV patients
2020 · Antonio Di Biagio, Elena Ricci, et al. · AIDS · 29
Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics
2004 · Giulia Marchetti, Luca Meroni, et al. · AIDS · 28
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study
2021 · Lucia Taramasso, Andrea De Vito, et al. · AIDS Patient Care and STDs · 26
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres
2022 · Agnese Comelli, Camilla Genovese, et al. · Antimicrobial Resistance and Infection Control · 23
PDF
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort
2025 · Roberta Gagliardini, Sara De Benedittis, et al. · Journal of Antimicrobial Chemotherapy · 22
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?
2022 · Paolo Maggi, Giuseppe Vittorio De Socio, et al. · BMC Infectious Diseases · 22
PDF
Safety of rezafungin as a long-term treatment option in two patients with complicated fungal infections: two cases from Lecco Hospital (Italy)
2024 · Giacomo Ponta, Valentina Morena, et al. · Antimicrobial Agents and Chemotherapy · 21
PDF
Comparison of three therapeutic regimens for genotype‐3 hepatitis C virus infection in a large real‐life multicentre cohort
2020 · Alessandro Soria, Marco Fava, et al. · Liver International · 21
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting
2023 · Paolo Maggi, Elena Delfina Ricci, et al. · Viruses · 19
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade
2021 · Lucia Taramasso, Paolo Bonfanti, et al. · HIV Medicine · 18
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort
2019 · Lucia Taramasso, Patrizia Lorenzini, et al. · Journal of Antimicrobial Chemotherapy · 18
PDF
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort
2020 · Paolo Bonfanti, Andrea De Vito, et al. · Infection and Drug Resistance · 17
PDF
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study
2019 · Roberta D’Ambrosio, Luisa Pasulo, et al. · Digestive and Liver Disease · 17
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project)
2012 · Barbara Menzaghi, Elena Ricci, et al. · Biomedicine & Pharmacotherapy · 17
Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study
2024 · Nicolò Corti, Barbara Menzaghi, et al. · Viruses · 16
PDF
Reversibility of Central Nervous System Adverse Events in Course of Art
2022 · Lucia Taramasso, Giancarlo Orofino, et al. · Viruses · 16
PDF
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort
2024 · Antonella d’Arminio Monforte, Alessandro Tavelli, et al. · Journal of Antimicrobial Chemotherapy · 15
PDF
Works count: 69
Citation count: 1,163
H-index: 18
I10-index: 34
Year
Topic
Type